By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ChromaDex, Inc. 

10005 Muirlands Boulevard
Suite G, First Floor
Irvine  California  92618  U.S.A.
Phone: 949-419-0288 Fax: 949-419-0294



Company News
ChromaDex, Inc. Initiates First Human Clinical Study To Confirm ChromaDex's NIAGEN™ Nicotinamide Riboside Will Increase NAD+ 7/16/2014 9:36:35 AM
Nobel Laureate Roger Kornberg To Chair New ChromaDex, Inc. Scientific Advisory Board 7/8/2014 10:22:51 AM
ChromaDex, Inc. Signs Collaboration Research Agreement With St. Jude Children's Research Hospital 6/19/2014 6:59:32 AM
ChromaDex, Inc. Licenses Exclusive Patent Rights From Dartmouth College For Pharmaceutical Use Of Nicotinamide Riboside (NR) 6/3/2014 9:18:58 AM
ChromaDex, Inc. CEO To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/30/2014 7:10:20 AM
ChromaDex, Inc. And JQMS Announce Exclusive Sales And Marketing Agreement For GMP Compliance Services 5/28/2014 9:09:45 AM
ChromaDex, Inc. Initiates Second Human Clinical Study For Its Caffeine Ingredient, PURENERGY® 5/14/2014 12:32:51 PM
ChromaDex, Inc. CEO To Present At 15th Annual B. Riley Conference On May 19th At 9:30 Am PDT / 12:30 Pm EDT 5/14/2014 6:56:04 AM
ChromaDex, Inc. Reports 32% Increase In First Quarter Revenue As Ingredient Sales Grow 97% 5/8/2014 7:00:47 AM
ChromaDex, Inc. Signs Material Transfer Agreement With Wageningen University For NIAGEN™ Research 5/5/2014 8:48:14 AM